Minimize Menorrhagia in Women With Von Willebrand Disease (VWDMin)
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Sponsor: Duke University
Terminated
The study stopped early due to slow recruitment.
Listed as NCT02606045, this PHASE3 trial focuses on Von Willebrand Diseases and remains terminated or withdrawn. Sponsored by Duke University, it has been updated 26 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
26 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Terminated PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
▶ Show 21 earlier versions
-
Jul 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE3
-
Feb 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Apr 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Apr 2020 — Jul 2020 [monthly]
Recruiting PHASE3
-
Jul 2019 — Apr 2020 [monthly]
Recruiting PHASE3
-
May 2019 — Jul 2019 [monthly]
Recruiting PHASE3
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE3
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Margaret Ragni
- National Heart, Lung, and Blood Institute (NHLBI)
- University of North Carolina
For direct contact, visit the study record on ClinicalTrials.gov .